Cargando...
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
BACKGROUND: Data on mepolizumab in patients with severe eosinophilic asthma (EA) and comorbidities are needed to assess whether randomized controlled trial results are applicable in the real world. OBJECTIVE: To evaluate real-life effectiveness and the presence/absence of predictors of treatment res...
Guardado en:
| Publicado en: | World Allergy Organ J |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
World Allergy Organization
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7508691/ https://ncbi.nlm.nih.gov/pubmed/32994855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2020.100462 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|